Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 7,966 | 3,461 | 372 | 0 | 0 |
| Cost of Goods | 652 | 309 | 48 | N/A | N/A |
| Gross Profit | 7,314 | 3,152 | 324 | N/A | N/A |
| Operating Expenses | 35,220 | 32,585 | 32,172 | 38,561 | 39,839 |
| Operating Income | -27,254 | -29,124 | -31,800 | -38,561 | -39,839 |
| Other Income | 102 | 308 | 451 | 768 | 866 |
| Pre-tax Income | -27,152 | -28,816 | -31,349 | -37,793 | -38,973 |
| Net Income Continuous | -30,526 | -28,816 | -31,349 | -37,793 | -38,973 |
| Net Income | $-30,526 | $-28,816 | $-31,349 | $-37,793 | $-38,973 |
| EPS Basic Total Ops | -1.36 | -1.31 | -1.44 | -1.79 | -1.87 |
| EPS Basic Continuous Ops | -1.37 | -1.31 | -1.44 | -1.79 | -1.87 |
| EPS Diluted Total Ops | -1.36 | -1.31 | -1.44 | -1.79 | -1.87 |
| EPS Diluted Continuous Ops | -1.37 | -1.31 | -1.44 | -1.79 | -1.87 |
| EBITDA(a) | $-27,080 | $-28,621 | $-31,802 | $-38,381 | $-39,806 |